FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,846,470 | -55.0% | 183,000 | 0.0% | 0.36% | -55.8% |
| Q3 2022 | $4,101,000 | -9.6% | 183,000 | 0.0% | 0.81% | -11.6% |
| Q2 2022 | $4,535,000 | -39.4% | 183,000 | -5.3% | 0.91% | -31.2% |
| Q1 2022 | $7,489,000 | -33.7% | 193,160 | 0.0% | 1.33% | -21.9% |
| Q4 2021 | $11,302,000 | -1.3% | 193,160 | 0.0% | 1.70% | +78.7% |
| Q3 2021 | $11,449,000 | -10.3% | 193,160 | +31.4% | 0.95% | -7.8% |
| Q2 2021 | $12,758,000 | +8.6% | 147,000 | +3.2% | 1.03% | +15.8% |
| Q1 2021 | $11,749,000 | +30.5% | 142,500 | +43.9% | 0.89% | +40.5% |
| Q4 2020 | $9,002,000 | – | 99,000 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |